Navigation Links
Chlamydia Vaccine a Step Closer to Reality

Scientists at Queensland University of Technology are one step closer to developing a world-first vaccine //to protect women against contracting the most common sexually-transmitted disease, Chlamydia.

A major international vaccine company has awarded QUT a funding boost of more than $300,000 to continue its research into Chlamydia and work towards developing a vaccine specifically targeting adolescent women.

Professor Peter Timms, from QUT's Institute of Health and Biomedical Innovation (IHBI), said a team of researchers had already identified certain proteins that were able to protect against Chlamydia infection.

"We've been testing these proteins as part of animal trials...and we think we've got the answer. It is possible that within three to five years we'll be finished the animal trials and be looking at clinical trials in humans."

Professor Timms said the funding would allow QUT to evaluate the effectiveness of Chlamydia prevention methods developed at the university, as well as compare and test possible other prevention methods being developed.

He said once a vaccine had been developed it could be administered via a patch, similar to ones used by smokers for nicotine.

"Patches are a good way to deliver proteins to a part of the body's immune system and they are also easy and user-friendly."

He said with rates of Chlamydia infection in some Australian communities as high as 12 per cent of the female population, there was a "real need" to develop a vaccine.

"Chlamydia is the most common infectious disease in the world and results in infertility in women and long-term chronic pelvic pain," he said.

"There are antibiotics to treat Chlamydia, but there's no vaccine to prevent it. In many cases women don't know they are infected because there are not really any physical signs or symptoms, so by and large they don't get treatment."

Professor Timm s said the fact that a large vaccine company had selected QUT to help develop Chlamydia vaccines points to the value of the work being done at the university.

"Despite this current injection of funds, further work and funding is still needed to take this current research through to a vaccine product," he said.

QUT researchers working on the project are part of IHBI's Cells and Tissue Domain and include Professors Peter Timms, Ken Beagley, Associate Professor Louise Hafner, Celia Berry and Chris Barker.

Source-Bio-Bio Technology
'"/>




Related medicine news :

1. Chlamydia toxin- a secret killer
2. One In Nine Young Women Diagnosed With Chlamydia Infection
3. UK Govt Says On Course For National Chlamydia Screening
4. Chlamydia Screening To Be Offered With Emergency Contraception
5. Home Chlamydia Test
6. Chlamydial Vaccine for Humans in the Pipeline
7. Mouse Model Demonstrates Immune System Reaction In Chlamydia Infection
8. Newly Identified Strains Of Chlamydia Trachomatis – A Gateway To New Disease
9. A Combined Research for Producing Chlamydia Vaccine Begins
10. Recurring Chlamydia Infections Common in Teenage Girls
11. Vaccine to quit smoking?
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/26/2016)... ... ... PawPaws brand pet supplements owned by Whole Health Supply is ... of felines. The formula is all-natural and is made from Chinese herbs that have ... Kidney Support Supplement Soft Chews are Astragalus Root Extract and Rehmannia Root Extract ...
(Date:6/25/2016)... ... 2016 , ... Experts from the American Institutes for Research ... June 26-28, 2016, at the Hynes Convention Center in Boston. , AIR experts ... planning, healthcare costs and patient and family engagement. , AIR researchers will be ...
(Date:6/25/2016)... Viejo, California (PRWEB) , ... June 25, 2016 , ... ... to fit their specific project," said Christina Austin - CEO of Pixel Film Studios. ... fully customizable and all within Final Cut Pro X . Simply select a ...
(Date:6/25/2016)... , ... June 25, 2016 , ... ... and non-athletes recover from injury. Recently, he has implemented orthobiologic procedures as a ... area —Johnson is one of the first doctors to perform the treatment. Orthobiologics ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published June ... with. The article goes on to state that individuals are now more comfortable seeking ... common operations such as calf and cheek reduction. The Los Angeles area medical group, ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... 2016 Any dentist who has made an implant ... process. Many of them do not even offer this as ... high laboratory costs involved. And those who ARE able to ... a high cost that the majority of today,s patients would ... Parsa Zadeh , founder of Dental Evolutions Inc. and inventor ...
(Date:6/23/2016)... LOS ANGELES , June 23, 2016 /PRNewswire/ ... (NASDAQ: CAPR ), a biotechnology company ... first-in-class therapeutics, today announced that patient enrollment in ... progrEssion in Duchenne) has exceeded 50% of its ... its enrollment in the third quarter of 2016, ...
(Date:6/23/2016)... 2016  Astellas today announced the establishment of Astellas Farma Colombia (AFC), a new affiliate with operations headquartered in ... America . ... ... ... ...
Breaking Medicine Technology: